Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02380768 · ClinicalTrials.gov registry record · NA
A Comparison of the Ambu AuraGain Versus LMA Supreme in Children
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02380768: Completed NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT02380768 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02380768, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.
Primary Outcome
The airway pressure at which an airway leak is observed after successful placement of the supraglottic airway
Interventions
- DEVICE Ambu AuraGain (size 1.5 or size 2.0)
- DEVICE LMA Supreme (size 1.5 or size 2.0)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02380768 record still lists
NCT02380768 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Ambu AuraGain (size 1.5 or size 2.0) is the first listed.
NCT02380768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02380768 about?
NCT02380768 is a clinical study titled "A Comparison of the Ambu AuraGain Versus LMA Supreme in Children". The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.
What is the current status of trial NCT02380768?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02380768?
The interventions under investigation include: Ambu AuraGain (size 1.5 or size 2.0) (DEVICE), LMA Supreme (size 1.5 or size 2.0) (DEVICE).
Who is sponsoring clinical trial NCT02380768?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02380768's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia